Lili Zhang

Company: Aprinoia Therapeutics Inc.

Job title: Senior Vice President & Head of Preclinical Development

Seminars:

Targeted Protein Degradation of Tau & Alpha-Synuclein For Preventing Neurodegeneration in Alzheimer’s & Parkinson’s Disease 1:30 pm

Harnessing protein degradation technology using dual function target binders and E3-ligase ligands to degrade pathological protein aggregates via the ubiquitinproteasome system Investigating selectivity and specificity of mechanism of action in cells and in vivo Using proprietary diagnostic radiotracers to select patients and provide both target engagement and efficacy readoutsRead more

day: Clinical & Commercial Track PM